Skip to Main Content

Author Details

Li Liu
College of Big Data & Software Engineering, Chongqing University
2005
31
18
PMIDPaper TitleJournal TitlePublished Year
36647008Identification of biomarkers predictive of metastasis development in early-stage colorectal cancer using network-based regularization.BMC Bioinformatics2023
37561583Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma.J Clin Invest2023
36927002Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade.J Clin Oncol2023
36475858Radiomic-based machine learning model for the accurate prediction of prostate cancer risk stratification.Br J Radiol2023
35273595The Lineage Differentiation and Dynamic Heterogeneity of Thymic Epithelial Cells During Thymus Organogenesis.Front Immunol2022
35795067Radiomics-Based Machine Learning Models for Predicting P504s/P63 Immunohistochemical Expression: A Noninvasive Diagnostic Tool for Prostate Cancer.Front Oncol2022
36439407Case report: Deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: Three cases reports.Front Oncol2022
36536472Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape.Genome Med2022
36085309Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development.Commun Biol2022
33475012Addressing resistance to immune checkpoint inhibitor therapy: an urgent unmet need.Future Oncol2021
33589643HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome.NPJ Genom Med2021
33861994Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy.Cancer Cell2021
34798882MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A.J Ovarian Res2021
30651857Long non-coding RNA XIST serves an oncogenic role in osteosarcoma by sponging miR-137.Exp Ther Med2019
30867688MicroRNA-186 promotes cell proliferation and inhibits cell apoptosis in cutaneous squamous cell carcinoma by targeting RETREG1.Exp Ther Med2019
29617665Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers.Cell Rep2018
28536309Development and Validation of an Ultradeep Next-Generation Sequencing Assay for Testing of Plasma Cell-Free DNA from Patients with Advanced Cancer.Clin Cancer Res2017
28389981Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors.Invest New Drugs2017
28150073First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors.Invest New Drugs2017
25945396The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy.Histopathology2016
27631521Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival.Am J Surg Pathol2016
27351836A Crowdsourcing Approach to Developing and Assessing Prediction Algorithms for AML Prognosis.PLoS Comput Biol2016
27165743Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients.Cancer Cell2016
25605368Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma.Blood2015
26208906TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer.Cancer Res2015
26200098Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.Am J Surg Pathol2015
20962848TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs.Nature2010
19197158SNM1B/Apollo interacts with astrin and is required for the prophase cell cycle checkpoint.Cell Cycle2009
18469862Snm1B/Apollo mediates replication fork collapse and S Phase checkpoint activation in response to DNA interstrand cross-links.Oncogene2008
16006804Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma.Am J Surg Pathol2005
16258509Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis.Mod Pathol2005
  • 1 - 31 of 31

Recommended Authors

Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 6
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
Jongmin Sim
Korea University Anam Hospital, Korea University College of Medicine
Career Start Year 2012
Number of shared co-authors 0
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 12
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 9
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
Liang Cao
National Cancer Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 0
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 4
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 1
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 1
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 1
Bin Feng
The First Affiliated Hospital of Jinan University
Career Start Year 2004
Number of shared co-authors 4
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 1
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2003
Number of shared co-authors 4
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 0
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 0
Karin Jirstr??m
Lund University
Career Start Year 2003
Number of shared co-authors 1
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 13
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 4
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 1
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 7
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 6
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 1
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 2
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 7
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 1

Collaborators

Raakhee Vijayaraghavan
Co-authored papers 5
Han Liang
MD Anderson Cancer Center
Co-authored papers 3
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Co-authored papers 3
Fengshen Kuo
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Timothy A Chan
Cleveland Clinic.
Co-authored papers 3
Timothy C Wang
Division of Gastroenterology and Irvine Cancer Research Center, Columbia University
Co-authored papers 2
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Luc G T Morris
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Yuan Yuan
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Abraham Ari Hakimi
Co-authored papers 2
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Stephen Welch
Victoria Hospital
Co-authored papers 2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2
Thomas J George
UF Health Cancer Center
Co-authored papers 1
Byron L Long
Rice University
Co-authored papers 1
Erik Engquist
Rice University
Co-authored papers 1
Thea Norman
Bill & Melinda Gates Foundation
Co-authored papers 1
Sante Gnerre
Co-authored papers 1
Farshad Farshidfar
Cumming School of Medicine, University of Calgary
Co-authored papers 1
David P Noren
Rice University
Co-authored papers 1
Oliver F Bathe
Cumming School of Medicine, University of Calgary
Co-authored papers 1
James Godsey
Illumina Inc.
Co-authored papers 1
Chen Hu
Johns Hopkins University School of Medicine
Co-authored papers 1
Yanxun Xu
Johns Hopkins University
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Andre Schultz
The University of Western Australia
Co-authored papers 1
Nianxiang Zhang
Co-authored papers 1
Amina A Qutub
University of Texas at San Antonio
Co-authored papers 1
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Release 1.2